OA07412A - Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique. - Google Patents
Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique.Info
- Publication number
- OA07412A OA07412A OA57984A OA57984A OA07412A OA 07412 A OA07412 A OA 07412A OA 57984 A OA57984 A OA 57984A OA 57984 A OA57984 A OA 57984A OA 07412 A OA07412 A OA 07412A
- Authority
- OA
- OAPI
- Prior art keywords
- benzoazacycloalhyl
- imidazolidines
- spiro
- therapy
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA07412A true OA07412A (fr) | 1984-11-30 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA57984A OA07412A (fr) | 1982-04-27 | 1983-04-27 | Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique. |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (cg-RX-API-DMAC7.html) |
| KR (1) | KR840004428A (cg-RX-API-DMAC7.html) |
| AT (1) | ATA125383A (cg-RX-API-DMAC7.html) |
| AU (1) | AU1395383A (cg-RX-API-DMAC7.html) |
| BE (1) | BE896572A (cg-RX-API-DMAC7.html) |
| DD (1) | DD209833A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3315106A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK183583A (cg-RX-API-DMAC7.html) |
| ES (1) | ES521895A0 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2525603A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2133401B (cg-RX-API-DMAC7.html) |
| GR (1) | GR78481B (cg-RX-API-DMAC7.html) |
| IL (1) | IL68497A0 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1167123B (cg-RX-API-DMAC7.html) |
| LU (1) | LU84770A1 (cg-RX-API-DMAC7.html) |
| MA (1) | MA19783A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL8301476A (cg-RX-API-DMAC7.html) |
| NO (1) | NO831473L (cg-RX-API-DMAC7.html) |
| OA (1) | OA07412A (cg-RX-API-DMAC7.html) |
| PT (1) | PT76595B (cg-RX-API-DMAC7.html) |
| SE (1) | SE8302347L (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA832927B (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| SI2332921T1 (sl) | 2003-06-17 | 2016-06-30 | Arena Pharmaceuticals, Inc. | 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid |
| EA016558B1 (ru) | 2003-06-17 | 2012-05-30 | Арена Фармасьютикалз, Инк. | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором |
| US8168624B2 (en) | 2004-12-21 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| EP2111859A1 (en) | 2004-12-23 | 2009-10-28 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
| JP5199997B2 (ja) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| WO2008070111A2 (en) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| CN102015591B (zh) | 2008-03-04 | 2014-01-29 | 艾尼纳制药公司 | 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法 |
| WO2010148207A2 (en) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| WO2011153206A1 (en) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| CN103189360A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
| KR20180094131A (ko) | 2010-09-01 | 2018-08-22 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신장 손상을 갖는 개체에 대한 로카세린의 투여 |
| SG188362A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| SG10201506870PA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Salts of lorcaserin with optically active acids |
| WO2014058441A1 (en) | 2012-10-09 | 2014-04-17 | Arena Pharmaceuticals, Inc. | Method of weight management |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Withdrawn
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 ES ES521895A patent/ES521895A0/es active Granted
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB8311508D0 (en) | 1983-06-02 |
| DE3315106A1 (de) | 1983-11-03 |
| GB2133401A (en) | 1984-07-25 |
| PT76595A (fr) | 1983-05-01 |
| SE8302347D0 (sv) | 1983-04-26 |
| FR2525603A1 (fr) | 1983-10-28 |
| FR2525603B1 (cg-RX-API-DMAC7.html) | 1984-09-14 |
| DK183583D0 (da) | 1983-04-26 |
| NL8301476A (nl) | 1983-11-16 |
| SE8302347L (sv) | 1983-10-28 |
| GB2133401B (en) | 1985-10-23 |
| ATA125383A (de) | 1986-05-15 |
| NO831473L (no) | 1983-10-28 |
| ZA832927B (en) | 1984-06-27 |
| ES8405796A1 (es) | 1984-06-16 |
| IT8348155A0 (it) | 1983-04-26 |
| MA19783A1 (fr) | 1983-12-31 |
| IL68497A0 (en) | 1983-07-31 |
| DK183583A (da) | 1983-10-28 |
| LU84770A1 (fr) | 1984-11-28 |
| KR840004428A (ko) | 1984-10-15 |
| JPS5910584A (ja) | 1984-01-20 |
| GR78481B (cg-RX-API-DMAC7.html) | 1984-09-27 |
| BE896572A (fr) | 1983-10-26 |
| ES521895A0 (es) | 1984-06-16 |
| DD209833A5 (de) | 1984-05-23 |
| PT76595B (fr) | 1986-01-21 |
| AU1395383A (en) | 1983-11-03 |
| IT1167123B (it) | 1987-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA19845A1 (fr) | Nouvelles piperidinamines et leur preparation | |
| FI832382A7 (fi) | Fenyylialfa- asyylioksiasetamidijohdannaiset ja niiden terapeuttinen käyttö. | |
| BR1100036A (pt) | Composto e composição farmacêutica | |
| LU81439A1 (fr) | Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique | |
| OA07412A (fr) | Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique. | |
| DE3378954D1 (en) | Perfluorocarbon emulsions and their preparation and use in therapy | |
| BE888396A (fr) | Capsules diagnostiques et therapeutiques et leur preparation, | |
| BE896018A (fr) | Amides pyrrolacetiques, leur preparation et leur utilisation | |
| FR2545825B1 (fr) | 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols, leur preparation et leurs utilisations therapeutiques | |
| OA07332A (fr) | Oximes-éthers, leur préparation et leur utilisation. | |
| BE882166A (fr) | 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique | |
| FI832519A7 (fi) | Farmaseuttisia menetelmiä ja koostumuksia. | |
| FI832520A7 (fi) | Farmaseuttisia menetelmiä ja koostumuksia. | |
| FR2568879B1 (fr) | Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique | |
| BE891585A (fr) | 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation | |
| BE877263A (fr) | 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique | |
| MA19965A1 (fr) | 3',5'-diarabinosides, leur preparation et leur application en therapeutique | |
| BE877328A (fr) | Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique | |
| BE874430A (fr) | 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique | |
| FR2544309B1 (fr) | Diphenylazomethines hydroxylees, leur preparation et leur application en therapeutique | |
| FR2522936B1 (fr) | Friandise fouettee et sa preparation | |
| BE882167A (fr) | (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique | |
| LU81350A1 (fr) | Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique | |
| NO834302L (no) | Uavhengig loepe- og sporrulle-loepeverk | |
| BE880288A (fr) | Hexahydro-2,6-methano-3-benzazocines, leur preparation et leur utilisation therapeutique |